Literature DB >> 1775411

Pulmonary fibrosis associated with nabumetone.

A Morice1, A Atherton, F Gleeson, S Stewart.   

Abstract

A patient is described who developed a rapid onset of pulmonary fibrosis following treatment with a new non-steroidal anti-inflammatory drug, nabumetone. Resolution of symptoms, physical signs and radiographic changes followed drug withdrawal and steroid therapy.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1775411      PMCID: PMC2399151          DOI: 10.1136/pgmj.67.793.1021

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  2 in total

1.  Alveolitis and haemolytic anaemia induced by azapropazone.

Authors:  M K Albazzaz; J E Harvey; J N Hoffman; J A Siddorn
Journal:  Br Med J (Clin Res Ed)       Date:  1986-12-13

2.  Fibrosing alveolitis: CT-pathologic correlation.

Authors:  N L Müller; R R Miller; W R Webb; K G Evans; D N Ostrow
Journal:  Radiology       Date:  1986-09       Impact factor: 11.105

  2 in total
  2 in total

1.  Hypereosinophilic syndrome: endomyocardial fibrosis.

Authors:  M Pitt; M K Davies; A J Brady
Journal:  Heart       Date:  1996-10       Impact factor: 5.994

2.  Nabumetone. A reappraisal of its pharmacology and therapeutic use in rheumatic diseases.

Authors:  H A Friedel; H D Langtry; M M Buckley
Journal:  Drugs       Date:  1993-01       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.